Viewing Study NCT05136768


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-06-01 @ 1:53 AM
Study NCT ID: NCT05136768
Status: UNKNOWN
Last Update Posted: 2021-11-29
First Post: 2021-11-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)
Sponsor: Jun-Lin Yi, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module